HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 182.40
Day range
kr 186.00 - kr 206.20
Year range
kr 160.00 - kr 519.00
Market cap
6.28B SEK
Avg Volume
134.07K
P/E ratio
56.78
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 178.30M | -15.24% |
Operating expense | 125.57M | 0.60% |
Net income | 1.57M | -94.22% |
Net profit margin | 0.88 | -93.19% |
Earnings per share | 0.04 | -95.34% |
EBITDA | 16.02M | -63.29% |
Effective tax rate | 147.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 323.00M | -32.82% |
Total assets | 2.39B | 5.03% |
Total liabilities | 295.46M | 19.05% |
Total equity | 2.09B | — |
Shares outstanding | 31.50M | — |
Price to book | 2.75 | — |
Return on assets | 0.76% | — |
Return on capital | 0.82% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 1.57M | -94.22% |
Cash from operations | 8.80M | -64.44% |
Cash from investing | -72.38M | -49.42% |
Cash from financing | 81.56M | 2,415.70% |
Net change in cash | 7.12M | 123.45% |
Free cash flow | -75.32M | -98.52% |
About
Founded
1998
Website
Employees
193
